Both in Pharmaceuticals
Ionis Pharmaceuticals vs Oruka Therapeutics
Over the past year IONS returned −45.1% and ORKA returned +280.1%; their daily moves had a correlation of 0.17.
IONS −45.1% ORKA +280.1%Growth of $1, one year, split-adjusted
| Metric | IONS | ORKA |
|---|---|---|
| Price | $40.42 | $99.55 |
| Market cap | $6.72B | $6.59B |
| Today | −1.99% | +4.32% |
| 1 month | −7.1% | +18.0% |
| 6 months | −46.3% | +44.4% |
| Year to date | −48.9% | +228.4% |
| 1 year | −45.6% | +253.4% |
| Revenue growth (YoY) | −40.7% | — |
| Gross margin | 99.0% | — |
| Net margin | −42.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.7× | — |
| Net cash | $732.0M | $873.6M |
| Dividend yield | — | — |
| Volatility (60d) | 43.7% | 51.7% |
| Short % of float | 12.6% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).